Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age- and body-weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism

Administered By

Awarded By

Contributors

Start/End

  • January 1, 2015 - June 29, 2018